Galmed Pharmaceuticals annual operating expenses
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Galmed Pharmaceuticals Operating Expenses Growth & History (GLMD)
Galmed Pharmaceuticals's operating expenses was $8.5M for fiscal 2025.
View full Galmed Pharmaceuticals company overviewGalmed Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.5M | $2.2M | +35.55% |
| 2024 | 2024-12-31 | $6.3M | −$1.2M | −16.20% |
| 2023 | 2023-12-31 | $7.5M | −$10.2M | −57.55% |
| 2022 | 2022-12-31 | $17.7M | −$15.2M | −46.32% |
| 2021 | 2021-12-31 | $32.9M | $2.7M | +8.84% |
| 2020 | 2020-12-31 | $30.2M | $7.8M | +35.01% |
| 2019 | 2019-12-31 | $22.4M | $11.7M | +108.83% |
| 2018 | 2018-12-31 | $10.7M | −$1.6M | −13.34% |
| 2017 | 2017-12-31 | $12.4M | −$4.5M | −26.76% |
| 2016 | 2016-12-31 | $16.9M | $6.0M | +55.24% |
| 2015 | 2015-12-31 | $10.9M | $1.7M | +18.96% |
| 2014 | 2014-12-31 | $9.1M | −$5.4M | −37.26% |
| 2013 | 2013-12-31 | $14.6M | $11.4M | +364.52% |
| 2012 | 2012-12-31 | $3.1M | — | — |
Galmed Pharmaceuticals quarterly operating expenses
Q2.15
Q2.16
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.8M | $666,000 | +31.58% |
| Q1 2026 | 2026-03-31 | $2.0M | $780,000 | +61.71% |
| Q4 2025 | 2025-12-31 | $3.0M | — | — |
| Q3 2025 | 2025-09-30 | $2.1M | $84,000 | +4.18% |
| Q2 2025 | 2025-06-30 | $2.1M | $887,000 | +72.59% |
| Q1 2025 | 2025-03-31 | $1.3M | — | — |
| Q3 2024 | 2024-09-30 | $2.0M | — | — |
| Q2 2024 | 2024-06-30 | $1.2M | −$649,000 | −34.69% |
| Q2 2023 | 2023-06-30 | $1.9M | −$1.9M | −49.84% |
| Q2 2022 | 2022-06-30 | $3.7M | −$4.7M | −55.66% |
| Q2 2021 | 2021-06-30 | $8.4M | $2.6M | +44.64% |
| Q2 2020 | 2020-06-30 | $5.8M | $1.1M | +23.72% |
| Q2 2019 | 2019-06-30 | $4.7M | $1.9M | +69.41% |
| Q2 2018 | 2018-06-30 | $2.8M | $74,000 | +2.74% |
| Q2 2017 | 2017-06-30 | $2.7M | −$1.5M | −36.01% |
| Q2 2016 | 2016-06-30 | $4.2M | $1.7M | +66.90% |
| Q2 2015 | 2015-06-30 | $2.5M | — | — |
Galmed Pharmaceuticals operating expenses trends
Over the last five fiscal years, Galmed Pharmaceuticals's operating expenses decreased from $30.2M to $8.5M, a change of −$21.7M. The latest reported quarter, Q2 2026, shows $2.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Galmed Pharmaceuticals source filings ↗